DOAJ
Open Access
2022
P1178: BRENTUXIMAB VEDOTIN IN COMBINATION WITH LENALIDOMIDE AND RITUXIMAB IN PATIENTS WITH RELAPSED/REFRACTORY DLBCL: SAFETY AND EFFICACY RESULTS FROM THE SAFETY RUN-IN PERIOD OF THE PHASE 3 ECHELON-3 STUDY
N. L. Bartlett
C. A. Yasenchak
K. K. Ashraf
W. N. Harwin
J. Orcutt
+6 lainnya
Topik & Kata Kunci
Penulis (11)
N
N. L. Bartlett
C
C. A. Yasenchak
K
K. K. Ashraf
W
W. N. Harwin
J
J. Orcutt
P
P. Kuriakose
P
P. L. Zinzani
A
A. Mamidipalli
K
K. Fenton
C
C. Glenn
G
G. Nowakowski
Format Sitasi
Bartlett, N.L., Yasenchak, C.A., Ashraf, K.K., Harwin, W.N., Orcutt, J., Kuriakose, P. et al. (2022). P1178: BRENTUXIMAB VEDOTIN IN COMBINATION WITH LENALIDOMIDE AND RITUXIMAB IN PATIENTS WITH RELAPSED/REFRACTORY DLBCL: SAFETY AND EFFICACY RESULTS FROM THE SAFETY RUN-IN PERIOD OF THE PHASE 3 ECHELON-3 STUDY. https://doi.org/10.1097/01.HS9.0000847576.88118.d6
Akses Cepat
PDF tidak tersedia langsung
Cek di sumber asli →Informasi Jurnal
- Tahun Terbit
- 2022
- Sumber Database
- DOAJ
- DOI
- 10.1097/01.HS9.0000847576.88118.d6
- Akses
- Open Access ✓